Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF) are caused by autoantibodies against keratinocyte adhesion molecules desmoglein 3 (Dsg3) and desmoglein 1 (Dsg1), respectively.
|
10551416 |
1999 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Pemphigus vulgaris (PV) and pemphigus foliaceus (PF), in which autoantibodies bind, respectively, to desmoglein 3 and desmoglein 1, are strongly associated with HLA-class II DR4 and DR14 alleles.
|
12604316 |
2003 |
Pemphigus
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pemphigus is a life-threatening blistering disorder of the skin and mucous membranes caused by pathogenic autoantibodies to desmosomal adhesion proteins desmoglein 3 (Dsg3) and Dsg1.
|
15841178 |
2005 |
Pemphigus Foliaceus
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pemphigus foliaceus (PF) and pemphigus vulgaris (PV) are autoimmune blistering diseases characterized by autoantibodies against desmoglein (Dsg)1 and Dsg3, respectively.
|
18219275 |
2008 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Pemphigus vulgaris (PV) is an acquired autoimmune blistering disorder in which greater than 80% of active patients produce autoantibodies to the desmosomal protein desmogelin 3 (Dsg3).
|
18564435 |
2008 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Pemphigus vulgaris (PV) is an autoimmune disease characterized by the presence of IgG autoantibodies against desmoglein-3.
|
28321152 |
2017 |
Pemphigus
|
0.100 |
Biomarker
|
disease |
BEFREE |
Pemphigus is an autoimmune blistering disease targeting the desmosomal proteins desmoglein (Dsg) 1 and Dsg3.
|
31057535 |
2019 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Pemphigus vulgaris is a rare chronic blistering skin disease resulting from IgG autoantibodies directed against transmembrane desmosomal glycoprotein desmoglein 3 and is the most common form of pemphigus.
|
31077459 |
2019 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Pemphigus vulgaris (PV) is an autoimmune disease characterized by blistering sores on skin and mucosal membranes, caused by autoantibodies primarily targeting the cellular adhesion protein, desmoglein-3 (Dsg3).
|
31340153 |
2019 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Pemphigus vulgaris (PV) is an autoimmune blistering disease, in which autoantibodies against PV antigen (PVA or Dsg3) play a pathogenic role in inducing blister formation.
|
8040292 |
1994 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Pemphigus vulgaris (PV) is a blistering disease of the skin and mucous membranes characterized by an autoantibody response against a keratinocyte adhesion molecule, desmoglein 3, causing acantholysis and blister formation.
|
9008309 |
1996 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Pemphigus vulgaris (PV) is an autoimmune disease mediated by autoantibodies that bind to a keratinocyte adhesion molecule, desmoglein-3.
|
9714477 |
1998 |
Pemphigus Vulgaris
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Desmoglein-3 (dsg-3) expressed in the suprabasal layer of the skin serves as an autoantigen in PV.
|
12653831 |
2003 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Dsg3-specific T-cell responses were detected in PV patients but also in healthy individuals who were either carriers of the PV-associated DRB1*0402 allele or alleles that share similar or identical peptide binding motifs to DRB1*0402.
|
12878355 |
2003 |
Adenocarcinoma
|
0.050 |
Biomarker
|
group |
BEFREE |
PVA and SFTPB are particularly powerful in tumors of squamous and adenocarcinoma histologies, respectively, whereas TACSTD1 is a good general marker for NSCLC metastasis.
|
16638856 |
2006 |
Non-Small Cell Lung Carcinoma
|
0.030 |
Biomarker
|
disease |
BEFREE |
PVA and SFTPB are particularly powerful in tumors of squamous and adenocarcinoma histologies, respectively, whereas TACSTD1 is a good general marker for NSCLC metastasis.
|
16638856 |
2006 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Desmoglein 3 is targeted in pemphigus vulgaris while desmoglein 1 is targeted in pemphigus foliaceus and its endemic form, Fogo Selvagem.
|
18838249 |
2008 |
Pemphigus Foliaceus
|
0.100 |
Biomarker
|
disease |
BEFREE |
Desmoglein 3 is targeted in pemphigus vulgaris while desmoglein 1 is targeted in pemphigus foliaceus and its endemic form, Fogo Selvagem.
|
18838249 |
2008 |
Pemphigus and fogo selvagem
|
0.020 |
Biomarker
|
disease |
BEFREE |
Desmoglein 3 is targeted in pemphigus vulgaris while desmoglein 1 is targeted in pemphigus foliaceus and its endemic form, Fogo Selvagem.
|
18838249 |
2008 |
Malignant Neoplasms
|
0.080 |
AlteredExpression
|
group |
BEFREE |
PVA levels had a trend toward association with clinical outcome, specifically time to death caused by cancer, but this was confounded by tumor stage.
|
23625795 |
2013 |
Primary malignant neoplasm
|
0.080 |
AlteredExpression
|
group |
BEFREE |
PVA levels had a trend toward association with clinical outcome, specifically time to death caused by cancer, but this was confounded by tumor stage.
|
23625795 |
2013 |
Tumor Cell Invasion
|
0.030 |
Biomarker
|
phenotype |
BEFREE |
Desmoglein 3 promotes cancer cell migration and invasion by regulating activator protein 1 and protein kinase C-dependent-Ezrin activation.
|
23752190 |
2014 |
Squamous cell carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
Desmoglein 3 (Dsg3), the pemphigus vulgaris antigen, has recently been shown to be upregulated in squamous cell carcinoma (SCC) and has been identified as a good tumor-specific marker for clinical staging of cervical sentinel lymph nodes in head and neck SCC.
|
23752190 |
2014 |
Pemphigus Vulgaris
|
0.300 |
Biomarker
|
disease |
BEFREE |
Dsg3-reactive T regulatory cells (Treg) have been previously identified in PV and healthy carriers of PV-associated HLA class II alleles.
|
26661498 |
2016 |
Oral Cavity Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Desmoglein 3 - Influence on oral carcinoma cell migration and invasion.
|
29969588 |
2018 |